Randomized Study of Single-Dose, Three-Day, and Seven-Day Treatment of Cystitis in Women

Publisher Website
Google Scholar
Abstract
We evaluated the following five treatment regimens for acute cystitis in nonpregnant women: cefadroxil, 1,000 mg single-dose; cefadroxil, 500 mg twice a day for three days; cefadroxil, 500 mg twice a day for seven days; trimethoprim-sulfamethoxazole (TMP-SMZ), 320–1,600 mg single-dose, and TMP-SMZ, 160–800 mg twice a day for three days. At four weeks after the end of treatment, 25070, 58070, 70%, 65%, and 88% of patients, respectively, remained cured of infection. The results indicated that three-day treatment (1) might improve cure rates (over single-dose), (2) would reduce incidence of relapse (vs. single-dose), and (3) may be as curative as seven-day treatment. The results of the antibody-coated bacteria test did not predict treatment failure or relapse.